/ARJO-B.ST
ARJO-B.ST Stock - Arjo AB (publ)
Healthcare|Medical - DistributionSTO
$31.52+0.06%
+$0.02 (+0.06%) • Dec 23
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.47
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.85
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $34.67
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ARJO-B.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$31.20 – $31.84
TARGET (TP)$36.25
STOP LOSS$29.00
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.88
52W High$41.02
52W Low$28.76
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $11.29B | $10.98B | $9.98B | $9.07B | $9.08B |
| Gross Profit | $4.91B | $4.74B | $4.21B | $4.21B | $4.13B |
| Gross Margin | 43.4% | 43.1% | 42.2% | 46.4% | 45.5% |
| Operating Income | $893.00M | $884.00M | $691.00M | $1.08B | $866.00M |
| Net Income | $498.00M | $480.00M | $449.00M | $742.00M | $526.00M |
| Net Margin | 4.4% | 4.4% | 4.5% | 8.2% | 5.8% |
| EPS | $1.83 | $1.76 | $1.65 | $2.72 | $1.93 |
Company Overview
Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and prevention of pressure injuries and leg ulcers, prevention of deep vein thrombosis, treatment of edema, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, as well as clinical consulting, maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. The company was founded in 1957 and is headquartered in Malmö, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ARJO-B.STBeat Rate
50%
Last 18 quarters
Avg Surprise
-1.7%
EPS vs Estimate
Beats / Misses
9/8
1 met exactly
Latest EPS
$0.30
Q4 2025
EPS Surprise History
Q1 24
+35.7%
$0.76vs$0.56
Q2 24
+13.5%
$0.59vs$0.52
Q3 24
-13.5%
$0.45vs$0.52
Q4 24
-29.3%
$0.29vs$0.41
Q1 25
+29.9%
$0.87vs$0.67
Q2 25
+8.9%
$0.61vs$0.56
Q3 25
-18.5%
$0.34vs$0.41
Q4 25
-58.7%
$0.30vs$0.72
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Jan 28, 2026 | — | — | — | — |
Q4 2025 | Oct 22, 2025 | $0.72 | $0.30 | -58.7% | ✗ MISS |
Q3 2025 | Jul 11, 2025 | $0.41 | $0.34 | -18.5% | ✗ MISS |
Q2 2025 | Apr 29, 2025 | $0.56 | $0.61 | +8.9% | ✓ BEAT |
Q1 2025 | Jan 30, 2025 | $0.67 | $0.87 | +29.9% | ✓ BEAT |
Q4 2024 | Oct 17, 2024 | $0.41 | $0.29 | -29.3% | ✗ MISS |
Q3 2024 | Jul 12, 2024 | $0.52 | $0.45 | -13.5% | ✗ MISS |
Q2 2024 | Apr 18, 2024 | $0.52 | $0.59 | +13.5% | ✓ BEAT |
Q1 2024 | Jan 30, 2024 | $0.56 | $0.76 | +35.7% | ✓ BEAT |
Q4 2023 | Oct 19, 2023 | $0.40 | $0.39 | -2.5% | ✗ MISS |
Q3 2023 | Jul 14, 2023 | $0.36 | $0.45 | +25.0% | ✓ BEAT |
Q2 2023 | Apr 20, 2023 | $0.34 | $0.42 | +23.5% | ✓ BEAT |
Q1 2023 | Jan 25, 2023 | $0.59 | $0.54 | -8.5% | ✗ MISS |
Q4 2022 | Oct 28, 2022 | $0.56 | $0.34 | -39.3% | ✗ MISS |
Q3 2022 | Jul 14, 2022 | $0.74 | $0.41 | -44.6% | ✗ MISS |
Q2 2022 | Apr 22, 2022 | $0.52 | $0.62 | +19.2% | ✓ BEAT |
Q1 2022 | Feb 3, 2022 | $0.77 | $0.77 | 0.0% | = MET |
Q4 2021 | Oct 28, 2021 | $0.63 | $0.71 | +12.7% | ✓ BEAT |
Q3 2021 | Jul 15, 2021 | $0.61 | $0.71 | +16.4% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about ARJO-B.ST
What is ARJO-B.ST's current stock price?
Arjo AB (publ) (ARJO-B.ST) is currently trading at $31.52 per share. The stock has moved +0.06% today.
What is the analyst price target for ARJO-B.ST?
No analyst price targets are currently available for this stock.
What sector is Arjo AB (publ) in?
Arjo AB (publ) operates in the Healthcare sector, specifically within the Medical - Distribution industry. The company is traded on the STO exchange.
What is ARJO-B.ST's market cap?
Arjo AB (publ) has a market capitalization of $8.59 billion, making it a mid-cap company.
Does ARJO-B.ST pay dividends?
No, Arjo AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMBEA.ST
Ambea AB (publ)
$141.30
Mkt Cap: $11.9B
ATT.ST
Attendo AB (publ)
$81.90
Mkt Cap: $12.4B
BIOG-B.ST
BioGaia AB (publ)
$102.40
Mkt Cap: $10.1B
CEVI.ST
CellaVision AB (publ)
$155.00
Mkt Cap: $3.7B
HUM.ST
Humana AB (publ)
$49.65
Mkt Cap: $2.4B
RAY-B.ST
RaySearch Laboratories AB (publ)
$224.50
Mkt Cap: $7.7B
SECARE.ST
Swedencare AB (publ)
$37.70
Mkt Cap: $6.0B
SUS.ST
Surgical Science Sweden AB (publ)
$32.06
Mkt Cap: $1.6B
SYNSAM.ST
Synsam AB (publ)
$66.50
Mkt Cap: $9.6B
XVIVO.ST
Xvivo Perfusion AB (publ)
$183.90
Mkt Cap: $5.8B
Explore stocks similar to ARJO-B.ST for comparison